0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA | 
Viewpoint | 
Walid F. Gellad, MD, MPH; Kathryn E. Flynn, PhD; G. Caleb Alexander, MD, MS
JAMA. 2015;314(9):869-870. doi:10.1001/jama.2015.8405.

JAMA Oncology | 
From The JAMA Network |  ONLINE FIRST
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA Oncol. Published online August 13, 2015. doi:10.1001/jamaoncol.2015.2274

JAMA Pediatrics | 
Viewpoint |  ONLINE FIRST
Jonathan M. Davis, MD; Mark A. Turner, MB, PhD, MRCPCH
JAMA Pediatr. Published online August 10, 2015. doi:10.1001/jamapediatrics.2015.1640

JAMA | 
The JAMA Forum |  FREE
Gail Wilensky, PhD
JAMA. 2015;314(5):440-441. doi:10.1001/jama.2015.8733.

JAMA Psychiatry | 
Original Investigation | 
Kenneth L. Subotnik, PhD; Laurie R. Casaus, MD; Joseph Ventura, PhD; et al.
JAMA Psychiatry. 2015;72(8):822-829. doi:10.1001/jamapsychiatry.2015.0270.
Includes: Supplemental Content

JAMA Internal Medicine | 
Original Investigation | 
Danilo Di Bona, MD, PhD; Antonella Plaia, PhD; Maria Stefania Leto-Barone, MD, PhD; et al.
JAMA Intern Med. 2015;175(8):1301-1309. doi:10.1001/jamainternmed.2015.2840.
Includes: Supplemental Content

JAMA Dermatology | 
JAMA Dermatology Clinicopathological Challenge | 
Shilpi Khetarpal, MD; Ivanka Kovalyshyn, DO; Anthony P. Fernandez, MD, PhD
JAMA Dermatol. 2015;151(8):891-892. doi:10.1001/jamadermatol.2015.74.

JAMA Psychiatry | 
Original Investigation | 
Joris Berwaerts, MD; Yanning Liu, MS; Srihari Gopal, MD, MHS; et al.
JAMA Psychiatry. 2015;72(8):830-839. doi:10.1001/jamapsychiatry.2015.0241.
Includes: CME, Supplemental Content

JAMA Internal Medicine | 
Original Investigation | 
Vinay Prasad, MD, MPH; Chul Kim, MD, MPH; Mauricio Burotto, MD; et al.
JAMA Intern Med. 2015;175(8):1389-1398. doi:10.1001/jamainternmed.2015.2829.
Includes: Supplemental Content

JAMA | 
Research Letter | 
Sonja M. Swenson, BA; Lisa J. Chamberlain, MD, MPH; Lee M. Sanders, MD, MPH; et al.
JAMA. 2015;314(4):405-407. doi:10.1001/jama.2015.7169.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Viewpoint  | 
Evaluation of Flibanserin Science and Advocacy at the FDA
Walid F. Gellad, MD, MPH; Kathryn E. Flynn, PhD; G. Caleb Alexander, MD, MS
JAMA Oncology
From The JAMA Network  | 
Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA Pediatrics
Viewpoint  | 
Global Collaboration to Develop New and Existing Drugs for Neonates
Jonathan M. Davis, MD; Mark A. Turner, MB, PhD, MRCPCH
JAMA
The JAMA Forum  | 
A New Focus on Prescription Drug Spending
Gail Wilensky, PhD